Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -64,923 | -132,065 | -88,481 | -86,908 | -90,865 |
| Depreciation Amortization | 454 | 807 | 863 | 797 | 923 |
| Income taxes - deferred | N/A | N/A | -367 | N/A | N/A |
| Accounts receivable | 6,138 | -4,875 | 186 | 139 | 149 |
| Accounts payable and accrued liabilities | 8,447 | -4,188 | -1,473 | 368 | 3,655 |
| Other Working Capital | 2,672 | 10,922 | 9,389 | -1,195 | -1,343 |
| Other Operating Activity | 99 | 109,324 | 1,558 | 19,232 | 35,347 |
| Operating Cash Flow | $-47,113 | $-20,075 | $-78,325 | $-67,567 | $-52,134 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -111 | -121 | -1,309 | -605 | -308 |
| Purchase Of Investment | -39,732 | -119,982 | -135,675 | -164,753 | -235,153 |
| Sale Of Investment | 89,041 | 86,144 | 183,204 | 177,986 | 67,829 |
| Purchase Sale Intangibles | N/A | -35,810 | N/A | N/A | N/A |
| Other Investing Activity | -833 | -35,810 | 0 | 0 | 0 |
| Investing Cash Flow | $48,365 | $-69,769 | $46,220 | $12,628 | $-167,632 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -11,483 |
| Common Stock Issued | N/A | 74,945 | 26,808 | 72,901 | 239,659 |
| Other Financing Activity | -5,862 | -409 | -102 | -34 | -3,124 |
| Financing Cash Flow | $-5,862 | $74,536 | $26,706 | $72,867 | $225,052 |
| Beginning Cash Position | 24,570 | 39,878 | 45,277 | 27,349 | 22,063 |
| End Cash Position | 19,960 | 24,570 | 39,878 | 45,277 | 27,349 |
| Net Cash Flow | $-4,610 | $-15,308 | $-5,399 | $17,928 | $5,286 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,113 | -20,075 | -78,325 | -67,567 | -52,134 |
| Capital Expenditure | -111 | -121 | -1,309 | -605 | -308 |
| Free Cash Flow | -47,224 | -20,196 | -79,634 | -68,172 | -52,442 |